{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:25:38Z","timestamp":1787109938338,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSTC112-2314-B016-015"],"award-info":[{"award-number":["NSTC112-2314-B016-015"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["TMUCOM202206"],"award-info":[{"award-number":["TMUCOM202206"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejps.2026.107628","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:17:15Z","timestamp":1785424635000},"page":"107628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Triplet radio-chemo-immunotherapy reprograms the PD-L1\u2013CDK6 axis to remodel the tumor microenvironment and overcome immune resistance in head and neck cancer"],"prefix":"10.1016","volume":"225","author":[{"given":"Chin-Sheng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Shou","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang Huong","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3805-0348","authenticated-orcid":false,"given":"Chi-Tun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107628_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1596583","article-title":"Advances and challenges in immunotherapy in head and neck cancer","volume":"16","author":"Aboaid","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2026.107628_bib0013","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2217\/imt-2017-0082","article-title":"Radiation therapy and immunotherapy: what is the optimal timing or sequencing?","volume":"10","author":"Aliru","year":"2018","journal-title":"Immunotherapy"},{"key":"10.1016\/j.ejps.2026.107628_bib0041","first-page":"17","article-title":"Reciprocal modulation of tumour and immune cell motility: uncovering dynamic interplays and therapeutic approaches","author":"Aquino","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejps.2026.107628_bib0018","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejps.2026.107628_bib0001","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7150\/ijms.3635","article-title":"Cancer and radiation therapy: current advances and future directions","volume":"9","author":"Baskar","year":"2012","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ejps.2026.107628_bib0016","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00066-023-02097-3","article-title":"Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review","volume":"199","author":"Becherini","year":"2023","journal-title":"Strahlenther. Onkol.: Organ Dtsch. Rontgenges. [et al.,]"},{"key":"10.1016\/j.ejps.2026.107628_bib0024","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fonc.2018.00612","article-title":"Radiation, immune checkpoint blockade and the abscopal effect: a critical review on timing, dose and fractionation","volume":"8","author":"Buchwald","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejps.2026.107628_bib0036","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12935-024-03351-z","article-title":"Cdk4\/6 inhibition enhances t-cell immunotherapy on hepatocellular carcinoma cells by rejuvenating immunogenicity","volume":"24","author":"Cai","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejps.2026.107628_bib0019","first-page":"12","article-title":"Role of cytokines and other soluble factors in tumor development: rationale for new therapeutic strategies","author":"Cavazzoni","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ejps.2026.107628_bib0012","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00262-024-03889-x","article-title":"Fractionated low-dose radiotherapy primes the tumor microenvironment for immunotherapy in a murine mesothelioma model","volume":"74","author":"D'Alonzo","year":"2025","journal-title":"Cancer Immunol. Immunother.: CII"},{"key":"10.1016\/j.ejps.2026.107628_bib0029","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fonc.2013.00128","article-title":"Radiotherapy effects on anti-tumor immunity: implications for cancer treatment","volume":"3","author":"Demaria","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejps.2026.107628_bib0043","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2003.09.012","article-title":"Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated","volume":"58","author":"Demaria","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ejps.2026.107628_bib0021","first-page":"14","article-title":"The renaissance of cyclin dependent kinase inhibitors","author":"Ettl","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejps.2026.107628_bib0025","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2026.107628_bib0005","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.3389\/fimmu.2018.03059","article-title":"Dendritic cells and cd8 t cell immunity in tumor microenvironment","volume":"9","author":"Fu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2026.107628_bib0026","first-page":"10","article-title":"How risk factors affect head and neck squamous cell carcinoma (hnscc) tumor immune microenvironment (time): their influence on immune escape mechanisms and immunotherapy strategy","author":"Galizia","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejps.2026.107628_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1457189","article-title":"Regulatory t cells: masterminds of immune equilibrium and future therapeutic innovations","volume":"15","author":"Ge","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2026.107628_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1483182","article-title":"Anti-pd1 therapies induce an early expansion of ki67(+)cd8(+) t cells in metastatic non-oncogene addicted nsclc patients","volume":"15","author":"Gelibter","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2026.107628_bib0015","first-page":"26","article-title":"Regulation and function of tumor-associated macrophages (tams) in colorectal cancer (crc): the role of the srif system in macrophage regulation","author":"Geltz","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107628_bib0028","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1470-2045(15)00054-6","article-title":"Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial","volume":"16","author":"Golden","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejps.2026.107628_bib0042","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41392-024-01938-6","article-title":"Circulating tumor cells: from new biological insights to clinical practice","volume":"9","author":"Gu","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ejps.2026.107628_bib0006","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fimmu.2013.00192","article-title":"Tumor-altered dendritic cell function: implications for anti-tumor immunity","volume":"4","author":"Hargadon","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2026.107628_bib0044","first-page":"65","article-title":"Radiotherapy combination opportunities leveraging immunity for the next oncology practice","volume":"67","author":"Herrera","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejps.2026.107628_bib0037","first-page":"8","article-title":"Cdk4\/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances t-cell activation in patients with sclc receiving chemotherapy","author":"Lai","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ejps.2026.107628_bib0051","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcancer.2017.12.007","article-title":"Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers","volume":"52","author":"Lhuillier","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejps.2026.107628_bib0014","first-page":"16","article-title":"Immunotherapies targeting tumor-associated macrophages (tams) in cancer","author":"Li","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107628_bib0048","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13046-025-03544-y","article-title":"The cgas\u2012sting pathway in colorectal cancer: bridging innate immunity and therapeutic strategies","volume":"44","author":"Li","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2026.107628_bib0040","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of pd-1\/pd-l1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejps.2026.107628_bib0011","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12016-025-09105-7","article-title":"Pd-1\/pd-l1 cancer immunotherapeutics reshape tumor microenvironment - clinical evidence and molecular mechanisms for ai-based precision medicine","volume":"68","author":"Lin","year":"2025","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.ejps.2026.107628_bib0023","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-018-0647-8","article-title":"Abscopal effect of radiotherapy combined with immune checkpoint inhibitors","volume":"11","author":"Liu","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejps.2026.107628_bib0008","first-page":"16","article-title":"Tumor vaccines: unleashing the power of the immune system to fight cancer","author":"Liu","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ejps.2026.107628_bib0032","first-page":"135","article-title":"Immunotherapeutic strategies in head and neck cancer: challenges and opportunities","author":"Liu","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2026.107628_bib0030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods (San Diego, Calif.)"},{"issue":"982\u2013997","key":"10.1016\/j.ejps.2026.107628_bib0004","article-title":"Dendritic cells can prime anti-tumor cd8(+) t cell responses through major histocompatibility complex cross-dressing","volume":"55","author":"MacNabb","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.ejps.2026.107628_bib0050","first-page":"131","article-title":"Myeloid cell-targeted stat3 inhibition sensitizes head and neck cancers to radiotherapy and t cell-mediated immunity","author":"Moreira","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2026.107628_bib0027","first-page":"12","article-title":"Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites","author":"Muijlwijk","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ejps.2026.107628_bib0038","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1509819","article-title":"Pd-l1 blockade enhances anti-tumor efficacy of nk cells","volume":"7","author":"Oyer","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ejps.2026.107628_bib0022","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.1158\/1078-0432.CCR-13-1675","article-title":"Dual cdk4\/cdk6 inhibition induces cell-cycle arrest and senescence in neuroblastoma","volume":"19","author":"Rader","year":"2013","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.ejps.2026.107628_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100867","article-title":"Synergizing radiotherapy and immunotherapy: current challenges and strategies for optimization","volume":"36","author":"Rajeev-Kumar","year":"2023","journal-title":"Neoplasia (New York, N.Y.)"},{"key":"10.1016\/j.ejps.2026.107628_bib0009","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ctrv.2015.03.011","article-title":"The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant","volume":"41","author":"Reynders","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ejps.2026.107628_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100092","article-title":"Targeting the adenosinergic axis in cancer immunotherapy: insights into a2a and a2b receptors and novel clinical combination strategies","volume":"77","author":"Rodr\u00edguez-Pamp\u00edn","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejps.2026.107628_bib0033","doi-asserted-by":"crossref","first-page":"573","DOI":"10.18632\/oncotarget.26542","article-title":"Increased pd-l1 expression in radioresistant hnscc cell lines after irradiation affects cell proliferation due to inactivation of gsk-3beta","volume":"10","author":"Schulz","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejps.2026.107628_bib0002","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41416-018-0201-z","article-title":"Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of marie curie?","volume":"119","author":"Thompson","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejps.2026.107628_bib0010","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3389\/fphar.2019.00511","article-title":"Abscopal effects in radio-immunotherapy-response analysis of metastatic cancer patients with progressive disease under anti-pd-1 immune checkpoint inhibition","volume":"10","author":"Trommer","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107628_bib0034","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.21037\/atm-22-6049","article-title":"Radiation-induced pd-l1 expression in tumor and its microenvironment facilitates cancer-immune escape: a narrative review","volume":"10","author":"Wang","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ejps.2026.107628_bib0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrclinonc.2016.211","article-title":"Radiotherapy and immunotherapy: a beneficial liaison?","volume":"14","author":"Weichselbaum","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejps.2026.107628_bib0017","doi-asserted-by":"crossref","first-page":"7378","DOI":"10.7150\/thno.113727","article-title":"Focusing on the interplay between tumor-associated macrophages and tumor microenvironment: from mechanism to intervention","volume":"15","author":"Wu","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.ejps.2026.107628_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37192","article-title":"Shaping the immune landscape: multidimensional environmental stimuli refine macrophage polarization and foster revolutionary approaches in tissue regeneration","volume":"10","author":"Xue","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejps.2026.107628_bib0003","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12943-025-02366-y","article-title":"Enhancing radiotherapy-induced anti-tumor immunity via nanoparticle-mediated sting agonist synergy","volume":"24","author":"Zeng","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejps.2026.107628_bib0046","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41392-022-01102-y","article-title":"Radiotherapy combined with immunotherapy: the dawn of cancer treatment","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejps.2026.107628_bib0047","first-page":"45","article-title":"Emerging mechanisms and implications of cgas-sting signaling in cancer immunotherapy strategies","volume":"21","author":"Zhang","year":"2024","journal-title":"Cancer Biol. Med."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:39:04Z","timestamp":1787107144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726002022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"alternative-id":["S0928098726002022"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107628","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triplet radio-chemo-immunotherapy reprograms the PD-L1\u2013CDK6 axis to remodel the tumor microenvironment and overcome immune resistance in head and neck cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107628"}}